Long‐term follow‐up of patients undergoing percutaneous suprapubic tube drainage after robot‐assisted radical prostatectomy (RARP)
Study Type – Therapy (case series) Level of Evidence 4 What's known on the subject? and What does the study add? • Initial reports of percutaneous suprapubic tube (PST) drainage following RARP demonstrated feasibility and short‐term safety, while decreasing patient discomfort and utilization o...
Saved in:
Published in | BJU international Vol. 110; no. 4; pp. 580 - 585 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford, UK
Blackwell Publishing Ltd
01.08.2012
Wiley-Blackwell Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
ISSN | 1464-4096 1464-410X 1464-410X |
DOI | 10.1111/j.1464-410X.2011.10786.x |
Cover
Loading…
Abstract | Study Type – Therapy (case series)
Level of Evidence 4
What's known on the subject? and What does the study add?
•
Initial reports of percutaneous suprapubic tube (PST) drainage following RARP demonstrated feasibility and short‐term safety, while decreasing patient discomfort and utilization of anti‐cholinergic medication.
•
This study demonstrates the long‐term safety and efficacy of bladder drainage by PST; splinting the urethrovesical anastomosis is simply not essential if mucosal apposition is ensured.
OBJECTIVES
•
To evaluate the long‐term safety and functional outcomes of patients undergoing percutaneous suprapubic tube (PST) drainage after robot‐assisted radical prostatectomy (RARP).
PATIENTS AND METHODS
•
Between January 2008 and October 2009, 339 patients undergoing RARP by one surgeon experienced in RA surgery (M.M.) had postoperative bladder drainage with PST and a minimum of 1‐year follow‐up for urinary function.
•
Functional outcomes were obtained via patient‐administered questionnaire.
•
Complications were captured by exhaustive review of multiple datasets, including our prospective prostate cancer database, claims data, as well as electronic medical and institutional morbidity and mortality records.
RESULTS
•
Urinary function assessed by patient‐administered questionnaire was analysed at a mean (sd) follow‐up of 11.5 (1.7) months; after RARP with PST placement, 293 patients (86.4%) had total urinary control and only nine (2.7%) required >1 pad/day.
•
In all, 86 patients (25.4%) never wore a pad; the median time to 0–1 pad/day was 2 weeks (interquartile range [IQR] 0,6); median time to total control was 6 weeks (IQR 1,22).
•
The mean (sd) follow‐up for complications was 23.7 (6.1) months. In all, 15 patients (4.4%) had a procedure‐specific complication, of which 13 were minor (Clavien Class I/II 3.8%); one patient had a bladder neck contracture.
•
In all, 16 patients (4.7%) required Foley placement after RARP for gross haematuria (two patients), urinary retention (three), tube malfunction (four) or need for prolonged Foley catheterization (seven).
CONCLUSIONS
•
PST placement after RARP is safe and efficacious on long‐term follow‐up.
•
Splinting of the urethrovesical anastomosis is not a critical step of RP if a watertight anastomosis and excellent mucosal apposition are achieved. |
---|---|
AbstractList | Study Type - Therapy (case series). Level of Evidence 4 What's known on the subject? and What does the study add? • Initial reports of percutaneous suprapubic tube (PST) drainage following RARP demonstrated feasibility and short-term safety, while decreasing patient discomfort and utilization of anti-cholinergic medication. • This study demonstrates the long-term safety and efficacy of bladder drainage by PST; splinting the urethrovesical anastomosis is simply not essential if mucosal apposition is ensured.
• To evaluate the long-term safety and functional outcomes of patients undergoing percutaneous suprapubic tube (PST) drainage after robot-assisted radical prostatectomy (RARP).
• Between January 2008 and October 2009, 339 patients undergoing RARP by one surgeon experienced in RA surgery (M.M.) had postoperative bladder drainage with PST and a minimum of 1-year follow-up for urinary function. • Functional outcomes were obtained via patient-administered questionnaire. • Complications were captured by exhaustive review of multiple datasets, including our prospective prostate cancer database, claims data, as well as electronic medical and institutional morbidity and mortality records.
• Urinary function assessed by patient-administered questionnaire was analysed at a mean (sd) follow-up of 11.5 (1.7) months; after RARP with PST placement, 293 patients (86.4%) had total urinary control and only nine (2.7%) required >1 pad/day. • In all, 86 patients (25.4%) never wore a pad; the median time to 0-1 pad/day was 2 weeks (interquartile range [IQR] 0,6); median time to total control was 6 weeks (IQR 1,22). • The mean (sd) follow-up for complications was 23.7 (6.1) months. In all, 15 patients (4.4%) had a procedure-specific complication, of which 13 were minor (Clavien Class I/II 3.8%); one patient had a bladder neck contracture. • In all, 16 patients (4.7%) required Foley placement after RARP for gross haematuria (two patients), urinary retention (three), tube malfunction (four) or need for prolonged Foley catheterization (seven).
• PST placement after RARP is safe and efficacious on long-term follow-up. • Splinting of the urethrovesical anastomosis is not a critical step of RP if a watertight anastomosis and excellent mucosal apposition are achieved. Study Type - Therapy (case series). Level of Evidence 4 What's known on the subject? and What does the study add? • Initial reports of percutaneous suprapubic tube (PST) drainage following RARP demonstrated feasibility and short-term safety, while decreasing patient discomfort and utilization of anti-cholinergic medication. • This study demonstrates the long-term safety and efficacy of bladder drainage by PST; splinting the urethrovesical anastomosis is simply not essential if mucosal apposition is ensured.UNLABELLEDStudy Type - Therapy (case series). Level of Evidence 4 What's known on the subject? and What does the study add? • Initial reports of percutaneous suprapubic tube (PST) drainage following RARP demonstrated feasibility and short-term safety, while decreasing patient discomfort and utilization of anti-cholinergic medication. • This study demonstrates the long-term safety and efficacy of bladder drainage by PST; splinting the urethrovesical anastomosis is simply not essential if mucosal apposition is ensured.• To evaluate the long-term safety and functional outcomes of patients undergoing percutaneous suprapubic tube (PST) drainage after robot-assisted radical prostatectomy (RARP).OBJECTIVES• To evaluate the long-term safety and functional outcomes of patients undergoing percutaneous suprapubic tube (PST) drainage after robot-assisted radical prostatectomy (RARP).• Between January 2008 and October 2009, 339 patients undergoing RARP by one surgeon experienced in RA surgery (M.M.) had postoperative bladder drainage with PST and a minimum of 1-year follow-up for urinary function. • Functional outcomes were obtained via patient-administered questionnaire. • Complications were captured by exhaustive review of multiple datasets, including our prospective prostate cancer database, claims data, as well as electronic medical and institutional morbidity and mortality records.PATIENTS AND METHODS• Between January 2008 and October 2009, 339 patients undergoing RARP by one surgeon experienced in RA surgery (M.M.) had postoperative bladder drainage with PST and a minimum of 1-year follow-up for urinary function. • Functional outcomes were obtained via patient-administered questionnaire. • Complications were captured by exhaustive review of multiple datasets, including our prospective prostate cancer database, claims data, as well as electronic medical and institutional morbidity and mortality records.• Urinary function assessed by patient-administered questionnaire was analysed at a mean (sd) follow-up of 11.5 (1.7) months; after RARP with PST placement, 293 patients (86.4%) had total urinary control and only nine (2.7%) required >1 pad/day. • In all, 86 patients (25.4%) never wore a pad; the median time to 0-1 pad/day was 2 weeks (interquartile range [IQR] 0,6); median time to total control was 6 weeks (IQR 1,22). • The mean (sd) follow-up for complications was 23.7 (6.1) months. In all, 15 patients (4.4%) had a procedure-specific complication, of which 13 were minor (Clavien Class I/II 3.8%); one patient had a bladder neck contracture. • In all, 16 patients (4.7%) required Foley placement after RARP for gross haematuria (two patients), urinary retention (three), tube malfunction (four) or need for prolonged Foley catheterization (seven).RESULTS• Urinary function assessed by patient-administered questionnaire was analysed at a mean (sd) follow-up of 11.5 (1.7) months; after RARP with PST placement, 293 patients (86.4%) had total urinary control and only nine (2.7%) required >1 pad/day. • In all, 86 patients (25.4%) never wore a pad; the median time to 0-1 pad/day was 2 weeks (interquartile range [IQR] 0,6); median time to total control was 6 weeks (IQR 1,22). • The mean (sd) follow-up for complications was 23.7 (6.1) months. In all, 15 patients (4.4%) had a procedure-specific complication, of which 13 were minor (Clavien Class I/II 3.8%); one patient had a bladder neck contracture. • In all, 16 patients (4.7%) required Foley placement after RARP for gross haematuria (two patients), urinary retention (three), tube malfunction (four) or need for prolonged Foley catheterization (seven).• PST placement after RARP is safe and efficacious on long-term follow-up. • Splinting of the urethrovesical anastomosis is not a critical step of RP if a watertight anastomosis and excellent mucosal apposition are achieved.CONCLUSIONS• PST placement after RARP is safe and efficacious on long-term follow-up. • Splinting of the urethrovesical anastomosis is not a critical step of RP if a watertight anastomosis and excellent mucosal apposition are achieved. Study Type – Therapy (case series) Level of Evidence 4 What's known on the subject? and What does the study add? • Initial reports of percutaneous suprapubic tube (PST) drainage following RARP demonstrated feasibility and short‐term safety, while decreasing patient discomfort and utilization of anti‐cholinergic medication. • This study demonstrates the long‐term safety and efficacy of bladder drainage by PST; splinting the urethrovesical anastomosis is simply not essential if mucosal apposition is ensured. OBJECTIVES • To evaluate the long‐term safety and functional outcomes of patients undergoing percutaneous suprapubic tube (PST) drainage after robot‐assisted radical prostatectomy (RARP). PATIENTS AND METHODS • Between January 2008 and October 2009, 339 patients undergoing RARP by one surgeon experienced in RA surgery (M.M.) had postoperative bladder drainage with PST and a minimum of 1‐year follow‐up for urinary function. • Functional outcomes were obtained via patient‐administered questionnaire. • Complications were captured by exhaustive review of multiple datasets, including our prospective prostate cancer database, claims data, as well as electronic medical and institutional morbidity and mortality records. RESULTS • Urinary function assessed by patient‐administered questionnaire was analysed at a mean (sd) follow‐up of 11.5 (1.7) months; after RARP with PST placement, 293 patients (86.4%) had total urinary control and only nine (2.7%) required >1 pad/day. • In all, 86 patients (25.4%) never wore a pad; the median time to 0–1 pad/day was 2 weeks (interquartile range [IQR] 0,6); median time to total control was 6 weeks (IQR 1,22). • The mean (sd) follow‐up for complications was 23.7 (6.1) months. In all, 15 patients (4.4%) had a procedure‐specific complication, of which 13 were minor (Clavien Class I/II 3.8%); one patient had a bladder neck contracture. • In all, 16 patients (4.7%) required Foley placement after RARP for gross haematuria (two patients), urinary retention (three), tube malfunction (four) or need for prolonged Foley catheterization (seven). CONCLUSIONS • PST placement after RARP is safe and efficacious on long‐term follow‐up. • Splinting of the urethrovesical anastomosis is not a critical step of RP if a watertight anastomosis and excellent mucosal apposition are achieved. Study Type - Therapy (case series) Level of Evidence4 What's known on the subject? and What does the study add? * Initial reports of percutaneous suprapubic tube (PST) drainage following RARP demonstrated feasibility and short-term safety, while decreasing patient discomfort and utilization of anti-cholinergic medication. * This study demonstrates the long-term safety and efficacy of bladder drainage by PST; splinting the urethrovesical anastomosis is simply not essential if mucosal apposition is ensured. OBJECTIVES * To evaluate the long-term safety and functional outcomes of patients undergoing percutaneous suprapubic tube (PST) drainage after robot-assisted radical prostatectomy (RARP). PATIENTS AND METHODS * Between January 2008 and October 2009, 339 patients undergoing RARP by one surgeon experienced in RA surgery (M.M.) had postoperative bladder drainage with PST and a minimum of 1-year follow-up for urinary function. * Functional outcomes were obtained via patient-administered questionnaire. * Complications were captured by exhaustive review of multiple datasets, including our prospective prostate cancer database, claims data, as well as electronic medical and institutional morbidity and mortality records. RESULTS * Urinary function assessed by patient-administered questionnaire was analysed at a mean (sd) follow-up of 11.5 (1.7) months; after RARP with PST placement, 293 patients (86.4%) had total urinary control and only nine (2.7%) required >1 pad/day. * In all, 86 patients (25.4%) never wore a pad; the median time to 0-1 pad/day was 2 weeks (interquartile range [IQR] 0,6); median time to total control was 6 weeks (IQR 1,22). * The mean (sd) follow-up for complications was 23.7 (6.1) months. In all, 15 patients (4.4%) had a procedure-specific complication, of which 13 were minor (Clavien Class I/II 3.8%); one patient had a bladder neck contracture. * In all, 16 patients (4.7%) required Foley placement after RARP for gross haematuria (two patients), urinary retention (three), tube malfunction (four) or need for prolonged Foley catheterization (seven). CONCLUSIONS * PST placement after RARP is safe and efficacious on long-term follow-up. * Splinting of the urethrovesical anastomosis is not a critical step of RP if a watertight anastomosis and excellent mucosal apposition are achieved. [PUBLICATION ABSTRACT] |
Author | Diaz, Mireya Sukumar, Shyam Trinh, Quoc‐Dien Kaul, Sanjeev Sammon, Jesse D. Simone, Andrea Menon, Mani |
Author_xml | – sequence: 1 givenname: Jesse D. surname: Sammon fullname: Sammon, Jesse D. – sequence: 2 givenname: Quoc‐Dien surname: Trinh fullname: Trinh, Quoc‐Dien – sequence: 3 givenname: Shyam surname: Sukumar fullname: Sukumar, Shyam – sequence: 4 givenname: Mireya surname: Diaz fullname: Diaz, Mireya – sequence: 5 givenname: Andrea surname: Simone fullname: Simone, Andrea – sequence: 6 givenname: Sanjeev surname: Kaul fullname: Kaul, Sanjeev – sequence: 7 givenname: Mani surname: Menon fullname: Menon, Mani |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26234557$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/22177263$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkcuKFDEYhYOMOBd9BQmIMC66TCqpqtRGGAevNCiDA-5CKpcmTVVS5sJM71y69Bl9EtPT3Qqzmmxy-3Ly_-ecgiPnnQYAYlThMl6vK0xbuqAYfa9qhHGFUcfa6vYROPl3cXRYo749BqcxrhEqB23zBBzXNe66uiUn4NfSu9Wfn7-TDhM0fhz9TdnlGXoDZ5GsdinC7JQOK2_dCs46yJyE0z5HGPMcxJwHK2HKg4YqCOvESkNhih4MfvCpqIkYbUxawSCUlWKEc_AxiaRl8tMGnl9dXH199RQ8NmKM-tl-PgPX7999u_y4WH758OnyYrmQtGbtYqDKGCoVLs30iNGeEoUlUX2tmSaKDqwzA9KCNobUTNTFCSlboQiTtaDGkDNwvtMtRfzIOiY-2Sj1OO564hgRhBhqOlTQF_fQtc_Bleo4Jg0hTd80rFDP91QeJq34HOwkwoYfPC7Ayz0gYuneBOGkjf-5tia0abrCvdlxstgTgzZc2uKS9S4VX8dSGd-Gz9d8myvfZsy34fO78PltEWD3BA5_PODp_u8bO-rNg9_xt5-v75bkL428y3M |
CODEN | BJINFO |
CitedBy_id | crossref_primary_10_4111_icu_2016_57_2_75 crossref_primary_10_1016_j_juro_2017_11_115 crossref_primary_10_1177_2051415817706635 crossref_primary_10_1089_end_2013_1588 crossref_primary_10_1016_j_juro_2013_03_031 crossref_primary_10_1016_j_ajur_2014_09_010 crossref_primary_10_3389_fsurg_2022_944561 crossref_primary_10_1007_s11701_014_0450_7 crossref_primary_10_1007_s00345_016_1883_6 crossref_primary_10_1016_j_eururo_2017_04_029 crossref_primary_10_1111_iju_12225 crossref_primary_10_1089_end_2012_0312 crossref_primary_10_1089_end_2012_0455 crossref_primary_10_1097_GCO_0b013e3283648d12 crossref_primary_10_23736_S2724_6051_20_04146_6 crossref_primary_10_1111_iwj_14443 crossref_primary_10_1007_s11934_020_00982_3 crossref_primary_10_1038_pcan_2017_26 crossref_primary_10_1089_end_2013_0564 crossref_primary_10_1111_bju_12071 crossref_primary_10_1016_j_juro_2014_01_004 crossref_primary_10_1155_2013_902686 crossref_primary_10_1016_j_ajur_2014_09_006 crossref_primary_10_1089_end_2015_0206 crossref_primary_10_1186_s12894_017_0312_5 crossref_primary_10_1007_s00345_020_03225_9 crossref_primary_10_1016_j_asjsur_2018_08_004 crossref_primary_10_1016_j_urology_2015_02_078 |
Cites_doi | 10.1002/bjs.5424 10.1016/S0022-5347(17)36966-5 10.1016/j.eururo.2009.01.036 10.1016/S0090-4295(00)01048-7 10.1016/j.eururo.2009.04.018 10.1016/j.eururo.2009.04.032 10.1046/j.1464-410x.2000.00670.x 10.1016/j.surg.2005.08.016 10.1097/01.ju.0000065860.16392.19 10.1038/sj.pcan.4500601 10.1016/j.eururo.2011.01.045 10.1016/S0090-4295(96)00491-8 10.1016/S0022-5347(05)67820-2 10.1016/j.eururo.2006.10.055 10.1016/S0022-5347(05)65648-0 10.1016/S0022-5347(05)67512-X 10.1097/01.ju.0000067464.53313.dd 10.1016/S0090-4295(01)01218-3 10.1016/S0090-4295(99)80237-4 10.1016/S0022-5347(17)40595-7 10.1111/j.1464-410X.2008.07875.x 10.1016/j.eururo.2009.04.019 10.1016/S0090-4295(00)00502-1 10.1038/sj.ijir.3900472 10.1016/S0022-5347(01)62202-X |
ContentType | Journal Article |
Copyright | 2011 THE AUTHORS. BJU INTERNATIONAL © 2011 BJU INTERNATIONAL 2015 INIST-CNRS 2011 THE AUTHORS. BJU INTERNATIONAL © 2011 BJU INTERNATIONAL. |
Copyright_xml | – notice: 2011 THE AUTHORS. BJU INTERNATIONAL © 2011 BJU INTERNATIONAL – notice: 2015 INIST-CNRS – notice: 2011 THE AUTHORS. BJU INTERNATIONAL © 2011 BJU INTERNATIONAL. |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7QP 7X8 |
DOI | 10.1111/j.1464-410X.2011.10786.x |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Calcium & Calcified Tissue Abstracts MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Calcium & Calcified Tissue Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic Calcium & Calcified Tissue Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1464-410X |
EndPage | 585 |
ExternalDocumentID | 2975490661 22177263 26234557 10_1111_j_1464_410X_2011_10786_x BJU10786 |
Genre | article Evaluation Studies Journal Article |
GroupedDBID | --- .3N .55 .GA .Y3 05W 0R~ 10A 1OB 1OC 23N 2WC 31~ 33P 36B 3O- 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 6P2 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHQN AAIPD AAMMB AAMNL AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABDBF ABEML ABJNI ABLJU ABOCM ABPVW ABQWH ABXGK ACAHQ ACCZN ACFBH ACGFS ACGOF ACMXC ACPOU ACPRK ACSCC ACUHS ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN AEFGJ AEIGN AEIMD AENEX AEUYR AEYWJ AFBPY AFEBI AFFNX AFFPM AFGKR AFWVQ AFZJQ AGHNM AGXDD AGYGG AHBTC AHMBA AIACR AIDQK AIDYY AITYG AIURR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ATUGU AZBYB AZVAB BAFTC BAWUL BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM DU5 E3Z EAD EAP EBC EBD EBS EJD EMB EMK EMOBN ESX EX3 F00 F01 F04 F5P FUBAC G-S G.N GODZA H.X HF~ HGLYW HZI HZ~ IHE IX1 J0M J5H K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PQQKQ Q.N Q11 QB0 R.K RJQFR ROL RX1 SUPJJ SV3 TEORI TUS UB1 V9Y W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WVDHM WXI WXSBR X7M XG1 YFH ZGI ZXP ~IA ~WT AAHHS AAYXX ACCFJ ADZOD AEEZP AEQDE AIWBW AJBDE CITATION IQODW CGR CUY CVF ECM EIF NPM 7QP 7X8 |
ID | FETCH-LOGICAL-c4286-b4dff4cd10019084943d1c3d92e8e3d4b87fb0ea45f328a2410cc6ad38c2a4ff3 |
IEDL.DBID | DR2 |
ISSN | 1464-4096 1464-410X |
IngestDate | Fri Sep 05 14:39:30 EDT 2025 Sat Jul 26 02:37:29 EDT 2025 Thu Apr 03 06:58:16 EDT 2025 Mon Jul 21 09:14:30 EDT 2025 Tue Jul 01 03:49:54 EDT 2025 Thu Apr 24 23:10:32 EDT 2025 Wed Aug 20 07:24:25 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | Human Nephrology robotic prostatectomy RARP Robotics Urology Percutaneous route suprapubic PST Treatment Telemedicine Follow up study Surgery Suprapubic drain Prostatectomy suprapubic tube |
Language | English |
License | CC BY 4.0 2011 THE AUTHORS. BJU INTERNATIONAL © 2011 BJU INTERNATIONAL. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4286-b4dff4cd10019084943d1c3d92e8e3d4b87fb0ea45f328a2410cc6ad38c2a4ff3 |
Notes | J.D.S. and Q.‐D.T. contributed equally. ObjectType-Article-1 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Article-2 ObjectType-Undefined-1 ObjectType-Feature-3 content type line 23 |
PMID | 22177263 |
PQID | 1353359558 |
PQPubID | 1026371 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_1030080570 proquest_journals_1353359558 pubmed_primary_22177263 pascalfrancis_primary_26234557 crossref_citationtrail_10_1111_j_1464_410X_2011_10786_x crossref_primary_10_1111_j_1464_410X_2011_10786_x wiley_primary_10_1111_j_1464_410X_2011_10786_x_BJU10786 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | August 2012 |
PublicationDateYYYYMMDD | 2012-08-01 |
PublicationDate_xml | – month: 08 year: 2012 text: August 2012 |
PublicationDecade | 2010 |
PublicationPlace | Oxford, UK |
PublicationPlace_xml | – name: Oxford, UK – name: Oxford – name: England – name: Edgecliff |
PublicationTitle | BJU international |
PublicationTitleAlternate | BJU Int |
PublicationYear | 2012 |
Publisher | Blackwell Publishing Ltd Wiley-Blackwell Wiley Subscription Services, Inc |
Publisher_xml | – name: Blackwell Publishing Ltd – name: Wiley-Blackwell – name: Wiley Subscription Services, Inc |
References | 2001; 166 2009; 56 2009; 55 2006; 93 1998; 160 2002; 5 1989; 141 1995; 46 2000; 55 2000; 85 2005; 138 1992; 148 1998 1999; 11 2000; 163 1997; 49 2005 2007; 51 2011; 59 2008; 102 2003; 169 2001; 57 2001; 58 e_1_2_7_5_2 e_1_2_7_4_2 e_1_2_7_3_2 e_1_2_7_2_2 e_1_2_7_9_2 e_1_2_7_8_2 e_1_2_7_7_2 e_1_2_7_6_2 e_1_2_7_19_2 Walsh PC (e_1_2_7_21_2) 1998 e_1_2_7_18_2 e_1_2_7_17_2 e_1_2_7_16_2 e_1_2_7_15_2 e_1_2_7_14_2 e_1_2_7_13_2 e_1_2_7_12_2 e_1_2_7_11_2 e_1_2_7_10_2 Niel‐Weise BS (e_1_2_7_23_2) 2005 e_1_2_7_26_2 e_1_2_7_27_2 e_1_2_7_28_2 e_1_2_7_25_2 e_1_2_7_24_2 e_1_2_7_22_2 e_1_2_7_20_2 |
References_xml | – volume: 85 start-page: 1067 year: 2000 end-page: 8 article-title: Early catheter removal in 100 consecutive patients undergoing radical retropubic prostatectomy publication-title: BJU Int – volume: 169 start-page: 2289 year: 2003 end-page: 92 article-title: Vattikuti Institute prostatectomy: technique publication-title: J Urol – volume: 49 start-page: 400 year: 1997 end-page: 3 article-title: Urethral catheter removal prior to hospital discharge following radical prostatectomy publication-title: Urology – volume: 169 start-page: 2170 year: 2003 end-page: 2 article-title: Early catheter removal after radical retropubic prostatectomy: long‐term followup publication-title: J Urol – volume: 163 start-page: 1643 year: 2000 end-page: 9 article-title: Laparoscopic radical prostatectomy: the Montsouris technique publication-title: J Urol – volume: 57 start-page: 742 year: 2001 end-page: 6 article-title: Anastomotic strictures following radical prostatectomy: insights into incidence, effectiveness of intervention, effect on continence, and factors predisposing to occurrence publication-title: Urology – volume: 148 start-page: 1549 year: 1992 end-page: 57 article-title: The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association publication-title: J Urol – volume: 55 start-page: 630 year: 2000 end-page: 4 article-title: Laparoscopic radical prostatectomy: preliminary results publication-title: Urology – volume: 163 start-page: 865 year: 2000 end-page: 6 article-title: Experience with early catheter removal after radical retropubic prostatectomy publication-title: J Urol – volume: 56 start-page: 89 year: 2009 end-page: 96 article-title: Vattikuti Institute prostatectomy: technical modifications in 2009 publication-title: Eur Urol – volume: 93 start-page: 1038 year: 2006 end-page: 44 article-title: A meta‐analysis comparing suprapubic and transurethral catheterization for bladder drainage after abdominal surgery publication-title: Br J Surg – volume: 5 start-page: 291 year: 2002 end-page: 5 article-title: Urethral catheter removal 3 days after radical retropubic prostatectomy is feasible and desirable publication-title: Prostate Cancer Prostatic Dis – volume: 56 start-page: 325 year: 2009 end-page: 30 article-title: Impact of percutaneous suprapubic tube drainage on patient discomfort after radical prostatectomy publication-title: Eur Urol – volume: 141 start-page: 79 year: 1989 end-page: 81 article-title: Radiographic assessment of the vesicourethral anastomosis directing early decatheterization following nerve‐sparing radical retropubic prostatectomy publication-title: J Urol – volume: 46 start-page: 429 year: 1995 end-page: 31 article-title: Early urethral catheter removal following radical prostatectomy: a pilot study publication-title: Urology – volume: 56 start-page: 331 year: 2009 article-title: Editorial comment on: impact of percutaneous suprapubic tube drainage on patient discomfort after radical prostatectomy publication-title: Eur Urol – volume: 51 start-page: 648 year: 2007 end-page: 58 article-title: Vattikuti Institute prostatectomy: contemporary technique and analysis of results publication-title: Eur Urol – volume: 11 start-page: 319 year: 1999 end-page: 26 article-title: Development and evaluation of an abridged, 5‐item version of the International Index of Erectile Function (IIEF‐5) as a diagnostic tool for erectile dysfunction publication-title: Int J Impot Res – volume: 55 start-page: 1037 year: 2009 end-page: 63 article-title: Retropubic, laparoscopic, and robot‐assisted radical prostatectomy: a systematic review and cumulative analysis of comparative studies publication-title: Eur Urol – volume: 58 start-page: 425 year: 2001 end-page: 9 article-title: Early removal of urinary catheter after radical retropubic prostatectomy is both feasible and desirable publication-title: Urology – volume: 166 start-page: 1662 year: 2001 end-page: 4 article-title: Early removal of the catheter after laparoscopic radical prostatectomy publication-title: J Urol – issue: 3 year: 2005 article-title: Urinary catheter policies for short‐term bladder drainage in adults publication-title: Cochrane Database Syst Rev – volume: 138 start-page: 837 year: 2005 end-page: 43 article-title: The NSQIP: a new frontier in surgery publication-title: Surgery – volume: 160 start-page: 2418 year: 1998 end-page: 24 article-title: Anatomic radical prostatectomy: evolution of the surgical technique publication-title: J Urol – volume: 59 start-page: 684 year: 2011 end-page: 98 article-title: Safety profile of robot‐assisted radical prostatectomy: a standardized report of complications in 3317 patients publication-title: Eur Urol – start-page: 2565 year: 1998 end-page: 88 – volume: 102 start-page: 1000 year: 2008 end-page: 4 article-title: Catheter‐less robotic radical prostatectomy using a custom‐made synchronous anastomotic splint and vesical urinary diversion device: report of the initial series and perioperative outcomes publication-title: BJU Int – ident: e_1_2_7_22_2 doi: 10.1002/bjs.5424 – ident: e_1_2_7_17_2 doi: 10.1016/S0022-5347(17)36966-5 – ident: e_1_2_7_3_2 doi: 10.1016/j.eururo.2009.01.036 – ident: e_1_2_7_24_2 doi: 10.1016/S0090-4295(00)01048-7 – ident: e_1_2_7_11_2 doi: 10.1016/j.eururo.2009.04.018 – start-page: 2565 volume-title: Campbell's Urology year: 1998 ident: e_1_2_7_21_2 – ident: e_1_2_7_15_2 doi: 10.1016/j.eururo.2009.04.032 – issue: 3 year: 2005 ident: e_1_2_7_23_2 article-title: Urinary catheter policies for short‐term bladder drainage in adults publication-title: Cochrane Database Syst Rev – ident: e_1_2_7_9_2 doi: 10.1046/j.1464-410x.2000.00670.x – ident: e_1_2_7_19_2 doi: 10.1016/j.surg.2005.08.016 – ident: e_1_2_7_7_2 doi: 10.1097/01.ju.0000065860.16392.19 – ident: e_1_2_7_5_2 doi: 10.1038/sj.pcan.4500601 – ident: e_1_2_7_20_2 doi: 10.1016/j.eururo.2011.01.045 – ident: e_1_2_7_26_2 doi: 10.1016/S0090-4295(96)00491-8 – ident: e_1_2_7_10_2 doi: 10.1016/S0022-5347(05)67820-2 – ident: e_1_2_7_16_2 doi: 10.1016/j.eururo.2006.10.055 – ident: e_1_2_7_8_2 doi: 10.1016/S0022-5347(05)65648-0 – ident: e_1_2_7_6_2 doi: 10.1016/S0022-5347(05)67512-X – ident: e_1_2_7_14_2 doi: 10.1097/01.ju.0000067464.53313.dd – ident: e_1_2_7_28_2 doi: 10.1016/S0090-4295(01)01218-3 – ident: e_1_2_7_27_2 doi: 10.1016/S0090-4295(99)80237-4 – ident: e_1_2_7_25_2 doi: 10.1016/S0022-5347(17)40595-7 – ident: e_1_2_7_12_2 doi: 10.1111/j.1464-410X.2008.07875.x – ident: e_1_2_7_13_2 doi: 10.1016/j.eururo.2009.04.019 – ident: e_1_2_7_4_2 doi: 10.1016/S0090-4295(00)00502-1 – ident: e_1_2_7_18_2 doi: 10.1038/sj.ijir.3900472 – ident: e_1_2_7_2_2 doi: 10.1016/S0022-5347(01)62202-X |
SSID | ssj0014665 |
Score | 2.2145267 |
Snippet | Study Type – Therapy (case series)
Level of Evidence 4
What's known on the subject? and What does the study add?
•
Initial reports of percutaneous suprapubic... Study Type - Therapy (case series). Level of Evidence 4 What's known on the subject? and What does the study add? • Initial reports of percutaneous suprapubic... Study Type - Therapy (case series) Level of Evidence4 What's known on the subject? and What does the study add? * Initial reports of percutaneous suprapubic... |
SourceID | proquest pubmed pascalfrancis crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 580 |
SubjectTerms | Biological and medical sciences Bladder Drainage - instrumentation Drainage - methods Equipment Failure Follow-Up Studies Humans Length of Stay Male Medical research Medical sciences Middle Aged Mortality Nephrology. Urinary tract diseases Organ Size Patient Satisfaction Patients Postoperative Complications - etiology Prostatectomy - adverse effects Prostatectomy - methods Prostatic Neoplasms - pathology Prostatic Neoplasms - surgery PST RARP robotic prostatectomy Robotics - methods suprapubic suprapubic tube Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases Surgery of the genital tract and mammary gland Urinary Catheterization - instrumentation Urinary Catheterization - methods Urination Disorders - etiology |
Title | Long‐term follow‐up of patients undergoing percutaneous suprapubic tube drainage after robot‐assisted radical prostatectomy (RARP) |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1464-410X.2011.10786.x https://www.ncbi.nlm.nih.gov/pubmed/22177263 https://www.proquest.com/docview/1353359558 https://www.proquest.com/docview/1030080570 |
Volume | 110 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Li9UwFA4yCxHE8W11HCK40EUvbd5djo9hGByRixfuLiRpM8jobemDUVcuXfob_SWetL2VDrMYxF1fJzTpOSdfmuT7EHpOJeFOZiL2jvCYQTjFiiobJ8RJaRORqV6m8-S9OFqx4zVfj-ufwl6YgR9i-uEWIqPP1yHAjW0uBjmLWZqsByZOGMgosQh4MqUi0Oi_WU5MUvBoryo5mABsny_qubSgWU91szINNJof1C4ug6NzdNt3T4e76GxbsWFVytmia-3Cfb_A-fh_an4b3RpRLD4Y3O4OulZs7qLrJ-M8_T308125Of3941fI-9iDq5XncNZVuPR4ZHJtcNi-Vp-W0HfiqqhdBzC1KLsGN11VG6jtJ4fbzhY4DyoWkPZwr2eO69KWLZQGqD-4aI5r08814SpsYDFhUqT88g2_WB4sP7y8j1aHbz--PopHzYfYwUBIxJbl3jOXB2qoLFEsYzRPHc0zUqiC5swq6W1SGMY9JcoA_kicEyanyhHDvKcP0M6m3BSPEDaygJ5Y-Iw5z9LcGcFlak3qFE8ocSRCcvt9tRsJ0YMux2c9GxgxHRpah4bWfUPrrxFKJ8tqIAW5gs3-zIUmQwIAlHEuI7S39Sk95pFGB1WSsHWaqwg9m25DBgjTOsNX0UEoDnA_l0mEHg6--LdwGHFKIijUtfeoK7-ufnW86g8f_7PlE3QDrpNhteQe2mnrrngKCK61-31s_gE6UzoY |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQkQAJ8X4ESjESBzhklTh27BzLo1rKboVWXWlvlu3YFaJsojzE48SRI7-RX8I4yS5K1UOFuCWKx4rtmfE3fsyH0POEE2Z4lobOEBZSMKdQJEKHETGc6yjNREfTOT9Kp0t6uGKrgQ7I34Xp80NsF9y8ZXT-2hu4X5A-a-U0pHG06lNxQiQj0gkAyssUcIePxN4strmkoGzHK9nLAHAfH-s5t6bRXHW9VDV0m-v5Ls4DpGN8201QBzfR6aZp_bmUT5O20RPz_UzWx__U9lvoxgBk8X6vebfRJbu-g67Mh636u-jnrFif_P7xy7t-7EDbii_w1pa4cHhI5lpjf4OtOilg-sSlrUwLSNUWbY3rtqwUNPejwU2rLc49kQV4PtxRmuOq0EUDtQHw91qa40p120249HdYlN8XKT5_wy8W-4sPL--h5cHb49fTcKB9CA3EQmmoae4cNbnPDpVFgmY0yWOT5BmxwiY51YI7HVlFmUuIUABBImNSlSfCEEWdS-6jnXWxtg8RVtzCZJy6jBpH49yolPFYq9gIFiXEkADxzQBLM-RE99Qcp3IUG1HpO1r6jpZdR8uvAYq3kmWfF-QCMnsjHdoKEsCglDEeoN2NUsnBldTSE5P429NMBOjZ9jM4Ab-z04-K9FxxAP0ZjwL0oFfGv5VD0MlJmkBbO5W68O_KV4fL7vHRP0s-RVenx_OZnL07ev8YXYMypD88uYt2mqq1TwDQNXqvM9Q_0pU-Nw |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Jb9QwFLZQkSokxL4ESjESBzhklDhO7BzLMiqlraoRI83N8lqhwiTKIpYTR478Rn4Jz0kmKFUPFeKWKH5W7Lzle7H9PoSeJ4ykmuVZ6DRJQwrmFPKEqzAimjEVZTnvaDqPjrP9JT1Ypath_5M_C9PXhxh_uHnL6Py1N_DSuPNGTkMaR6u-EickMjybAZ68SjMAFh4gLcZSUtC2o5XsZQC3T3f1XNjTJFRdL2UNs-Z6uouL8OgU3nbxaX4TnW1G1m9LOZu1jZrp7-eKPv6fod9CNwYYi_d6vbuNrtj1HbR9NCzU30U_D4v16e8fv7zjxw50rfgCd22JC4eHUq419ufXqtMCgicubaVbwKm2aGtct2UlYbQfNW5aZbHxNBbg93BHaI6rQhUN9Aaw3-uowZXsFptw6U-wSL8qUnz-hl8s9hYnL--h5fzth9f74UD6EGrIhLJQUeMc1cbXhsojTnOamFgnJieW28RQxZlTkZU0dQnhEgBIpHUmTcI1kdS55D7aWhdr-xBhySyE4szlVDsaGy2zlMVKxpqnUUI0CRDbfF-hh4ronpjjk5hkRlT4iRZ-okU30eJrgOJRsuyrglxCZneiQqMgAQRK05QFaGejU2JwJLXwtCT-7HTKA_RsfAwuwK_r9F9FeKY4AP4piwL0oNfFv51DyslIlsBYO4269OuKVwfL7vLRP0s-Rdsnb-bi8N3x-8foGjQh_c7JHbTVVK19AmiuUbudmf4B3vI85g |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Long%E2%80%90term+follow%E2%80%90up+of+patients+undergoing+percutaneous+suprapubic+tube+drainage+after+robot%E2%80%90assisted+radical+prostatectomy+%28RARP%29&rft.jtitle=BJU+international&rft.au=Sammon%2C+Jesse+D.&rft.au=Trinh%2C+Quoc%E2%80%90Dien&rft.au=Sukumar%2C+Shyam&rft.au=Diaz%2C+Mireya&rft.date=2012-08-01&rft.pub=Blackwell+Publishing+Ltd&rft.issn=1464-4096&rft.eissn=1464-410X&rft.volume=110&rft.issue=4&rft.spage=580&rft.epage=585&rft_id=info:doi/10.1111%2Fj.1464-410X.2011.10786.x&rft.externalDBID=10.1111%252Fj.1464-410X.2011.10786.x&rft.externalDocID=BJU10786 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1464-4096&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1464-4096&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1464-4096&client=summon |